TrialCancer immunology, immunotherapy : CII2011
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.
Goki Shindo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.